Emma C Samelson-Jones, MD
Psychiatry · Castro Valley
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 10
- 2 carriers
- Offices
- 4
- Since medical school
- 17 years
- University of California, San Francisco School of Medicine, 2009
Offices
4 locations · University Healthcare Alliance · University of California San Francisco · UCSF Medical Group Business Services
Looking this up.
Hospitals listed: UCSF Medical Center. That is not proof they admit you there this week.
Plans that list them
10 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Samelson-Jones’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
10 of 10 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Medicare Advantage (HMO-POS) | Anthem Blue Cross | Listed | Oct 3, 2026 |
California Medical Board record
Licence A125619 · Current
Licensed to practise in California · since 2013 · expires 2027-04-30 · University of California San Francisco School of Medicine.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- UCSF Medical CenterSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of University of California Health, which runs 12 hospitalsHome of UCSF Helen Diller Family Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 4.9 (3.79 to 6.02) · 7,590 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 12.8 (11.3 to 14.4) · 2,019 cases, Jan 2024 – Dec 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 139.4 (110.22 to 168.58) · 452 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.622, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.626, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.491, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.7 to 1) · 2,336 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for UCSF Medical Center
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 3 better, 5 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.9 (3.79 to 6.02) · 7,590 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.8 (11.3 to 14.4) · 2,019 cases | Worse | Jan 2024 – Dec 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 139.4 (110.22 to 168.58) · 452 cases | Better | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.622 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.626 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.491 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.7 to 1) · 2,336 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.24 (0.58 to 1.9) · 4,689 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.89 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.5 · 85 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.1 · 132 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.6 · 454 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 618 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 380 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.7 · 5,000 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.06 to 0.38) · 15,965 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.05 to 0.35) · 17,859 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.85 (0 to 1.83) · 4,184 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2 (1.1 to 2.9) · 6,516 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.35 (4.49 to 10.21) · 3,989 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5 (3.22 to 6.77) · 4,087 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.95 (0.74 to 3.15) · 2,034 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.95 (0.63 to 1.28) · 15,431 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 399 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.899 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.689 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.224 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16 · 156 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20 · 564 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 60.3 · 160 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -9.7 · 550 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 44.1 · 660 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 667 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (4.8 to 6.7) · 2,019 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6 · 421 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 107 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.9 (11.3 to 17.1) · 3,247 cases | No different | Jan 2022 – Dec 2024 |
What patients said (3,181 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 50% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$28,211
Medicare paid this office $28,211 for 81 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 47 | $9,675 | $82 |
| Return visit (30+ min) | 32 | $8,768 | $80 |
| Psychotherapy with evaluation and management visit, 30 minutes | 19 | $3,300 | $49 |
| Psychiatric diagnostic evaluation with medical services | 11 | $1,476 | $134 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 23 | $1,052 | $15 |
See all 6 services
| Return visit (30+ min) | 47 | $9,675 | $82 |
| Return visit (30+ min) | 32 | $8,768 | $80 |
| Psychotherapy with evaluation and management visit, 30 minutes | 19 | $3,300 | $49 |
| Psychiatric diagnostic evaluation with medical services | 11 | $1,476 | $134 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 23 | $1,052 | $15 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 33 | $948 | $15 |
Who their Medicare patients are
81 Original Medicare patients in 2024. Average age 68 · Women 68% · Also on Medicaid 35% · Health risk score 1.68. Above the middle of the specialty; the typical psychiatry clinician is at 1.35.
Conditions among them: Depression 75% · High blood pressure 59% · Chronic kidney disease 32% · Diabetes 22% · Cancer 15% · Dementia 15% · COPD 14%.
The office billed $197,435, Medicare allowed $37,993 and paid $28,211; for 498 services of 8 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 81 | 498 | 68 | 1.68 | $197,435 | $28,211 |
| 2023 | 107 | 352 | 69 | 1.46 | $188,173 | $28,166 |
| 2022 | 75 | 200 | 66 | 1.40 | $101,311 | $15,465 |
| 2021 | 129 | 502 | 64 | 1.64 | $237,537 | $35,284 |
| 2020 | 120 | 633 | 63 | 2.03 | $313,947 | $41,785 |
| 2019 | 129 | 439 | 65 | 1.56 | $229,419 | $29,147 |
| 2018 | 111 | 385 | 60 | 1.44 | $191,408 | $24,218 |
| 2017 | 94 | 414 | 61 | 1.48 | $182,693 | $24,200 |
| 2016 | 72 | 270 | 61 | 1.37 | $120,032 | $17,637 |
| 2015 | 11 | 51 | 55 | 1.65 | $22,218 | $3,567 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Return visit (30+ min) | 29 | $9,337 | $86 |
| Return visit (30+ min) | 64 | $8,771 | $85 |
| Psychotherapy with evaluation and management visit, 30 minutes | 19 | $3,366 | $51 |
| Psychiatric diagnostic evaluation with medical services | 15 | $2,255 | $150 |
| Long return visit (40+ min) | 12 | $1,549 | $129 |
2022: 3 services
| Return visit (30+ min) | 48 | $5,716 | $85 |
| Return visit (30+ min) | 20 | $4,027 | $88 |
| Psychotherapy with evaluation and management visit, 30 minutes | 13 | $1,365 | $55 |
2021: 6 services
| Return visit (30+ min) | 70 | $12,349 | $86 |
| Return visit (30+ min) | 36 | $8,686 | $83 |
| Psychotherapy with evaluation and management visit, 30 minutes | 27 | $4,165 | $51 |
| Psychotherapy with evaluation and management visit, 30 minutes | 16 | $2,938 | $52 |
| Short return visit (20+ min) | 20 | $2,584 | $57 |
| Telephone medical discussion with physician, 5-10 minutes | 12 | $551 | $32 |
2020: 5 services
| Return visit (30+ min) | 69 | $15,517 | $69 |
| Return visit (30+ min) | 41 | $8,913 | $68 |
| Psychotherapy with evaluation and management visit, 30 minutes | 11 | $5,376 | $58 |
| Psychotherapy with evaluation and management visit, 30 minutes | 29 | $5,050 | $53 |
| Psychiatric diagnostic evaluation with medical services | 19 | $2,272 | $120 |
2019: 4 services
| Return visit (30+ min) | 40 | $9,507 | $68 |
| Return visit (30+ min) | 64 | $8,796 | $66 |
| Psychotherapy with evaluation and management visit, 30 minutes | 29 | $5,180 | $56 |
| Psychiatric diagnostic evaluation with medical services | 22 | $2,746 | $119 |
2018: 5 services
| Return visit (30+ min) | 61 | $7,995 | $62 |
| Return visit (30+ min) | 36 | $6,740 | $66 |
| Psychotherapy with evaluation and management visit, 30 minutes | 22 | $3,916 | $52 |
| Psychiatric diagnostic evaluation with medical services | 22 | $2,312 | $105 |
| Short return visit (20+ min) | 18 | $1,018 | $42 |
2017: 5 services
| Return visit (30+ min) | 59 | $7,774 | $58 |
| Psychotherapy with evaluation and management visit, 30 minutes | 18 | $4,871 | $54 |
| Return visit (30+ min) | 21 | $4,313 | $72 |
| Short return visit (20+ min) | 24 | $3,530 | $42 |
| Psychiatric diagnostic evaluation with medical services | 17 | $2,085 | $116 |
2016: 5 services
| Return visit (30+ min) | 38 | $5,664 | $69 |
| Psychiatric diagnostic evaluation with medical services | 22 | $2,684 | $117 |
| Return visit (30+ min) | 13 | $2,518 | $79 |
| Psychotherapy with evaluation and management visit, 30 minutes | 12 | $1,983 | $57 |
| Short return visit (20+ min) | 18 | $1,833 | $47 |
Drugs they prescribed that Part D paid
$3,822
Pharmacies billed $3,822 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 244) in 2024. At or below the middle of the specialty; the typical psychiatry clinician is at 0%.
235 generic and fewer than 11 brand-name prescriptions · $3,822 in drug cost · 44 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Olanzapine | 24 | $438 | $18 |
| Gabapentin | 17 | $268 | $16 |
| Sertraline | 18 | $130 | $7 |
| Escitalopram | 15 | $117 | $8 |
| Trazodone | 18 | $114 | $6 |
See all 9 drugs
| Olanzapine | 24 | $438 | $18 |
| Gabapentin | 17 | $268 | $16 |
| Sertraline | 18 | $130 | $7 |
| Escitalopram | 15 | $117 | $8 |
| Trazodone | 18 | $114 | $6 |
| Quetiapine Fumarate Er | 14 | $111 | $8 |
| Lorazepam | 11 | $40 | $4 |
| Mirtazapine | 12 | $38 | $3 |
| Zolpidem | 11 | $22 | $2 |
Year by year
| 2024 | 244 | 34 | 0% (0) | None | $3,822 |
| 2023 | 281 | 36 | 0% (0) | 7% | $10,961 |
| 2022 | 119 | 26 | 0% (0) | None | $3,410 |
| 2021 | 687 | 95 | 0% (0) | None | $30,624 |
| 2020 | 841 | 108 | 0% (0) | 7% | $57,044 |
| 2019 | 770 | 119 | 0% (0) | 10% | $77,836 |
| 2018 | 591 | 96 | 0% (0) | 7% | $47,918 |
| 2017 | 461 | 83 | None | 10% | $55,386 |
| 2016 | 295 | 58 | None | 5% | $23,008 |
| 2015 | 976 | 76 | 0% (0) | 14% | $106,817 |
| 2014 | 995 | 66 | 0% (0) | 11% | $123,847 |
| 2013 | 113 | 19 | 0% (0) | 15% | $19,726 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 12 drugs
| Olanzapine | 18 | $1,410 | $78 |
| Dextroamphetamine-Amphet Er | 12 | $596 | $50 |
| Gabapentin | 18 | $340 | $19 |
| Trazodone | 19 | $335 | $18 |
| Dextroamphetamine-Amphetamine | 11 | $315 | $29 |
| Bupropion Xl | 14 | $246 | $18 |
| Mirtazapine | 12 | $197 | $16 |
| Escitalopram | 14 | $188 | $13 |
| Sertraline | 28 | $164 | $6 |
| Risperidone | 11 | $162 | $15 |
| Lithium Carbonate Er | 12 | $135 | $11 |
| Lorazepam | 12 | $39 | $3 |
2022: 2 drugs
| Sertraline | 12 | $208 | $17 |
| Trazodone | 11 | $132 | $12 |
2021: 21 drugs
| Bupropion Xl | 56 | $2,936 | $52 |
| Venlafaxine Hcl Er | 39 | $1,853 | $48 |
| Duloxetine | 32 | $1,780 | $56 |
| Quetiapine | 35 | $1,571 | $45 |
| Aripiprazole | 16 | $1,168 | $73 |
| Olanzapine | 36 | $1,074 | $30 |
| Mirtazapine | 30 | $684 | $23 |
| Divalproex | 23 | $650 | $28 |
| Trazodone | 22 | $593 | $27 |
| Escitalopram | 43 | $530 | $12 |
| Gabapentin | 25 | $466 | $19 |
| Sertraline | 13 | $353 | $27 |
| Lithium Carbonate | 36 | $333 | $9 |
| Buspirone | 20 | $321 | $16 |
| Lithium Carbonate Er | 19 | $321 | $17 |
| Hydroxyzine | 20 | $318 | $16 |
| Bupropion Hcl Sr | 14 | $268 | $19 |
| Fluoxetine | 15 | $248 | $17 |
| Clonazepam | 29 | $221 | $8 |
| Risperidone | 16 | $172 | $11 |
| Lamotrigine | 16 | $137 | $9 |
2020: 24 drugs
| Bupropion Xl | 92 | $3,971 | $43 |
| Trazodone | 28 | $2,191 | $78 |
| Duloxetine | 45 | $1,794 | $40 |
| Mirtazapine | 48 | $1,728 | $36 |
| Venlafaxine Hcl Er | 39 | $1,470 | $38 |
| Quetiapine | 32 | $941 | $29 |
| Divalproex | 31 | $910 | $29 |
| Olanzapine | 34 | $689 | $20 |
| Liothyronine | 11 | $681 | $62 |
| Methylphenidate | 17 | $529 | $31 |
| Lithium Carbonate | 44 | $523 | $12 |
| Sertraline | 20 | $435 | $22 |
| Lamotrigine | 28 | $340 | $12 |
| Clonazepam | 25 | $318 | $13 |
| Gabapentin | 15 | $249 | $17 |
| Escitalopram | 29 | $249 | $9 |
| Risperidone | 23 | $239 | $10 |
| Paroxetine | 16 | $168 | $10 |
| Lorazepam | 22 | $159 | $7 |
| Hydroxyzine | 11 | $129 | $12 |
| Lithium Carbonate Er | 13 | $128 | $10 |
| Zolpidem | 18 | $114 | $6 |
| Buspirone | 12 | $100 | $8 |
| Fluoxetine | 17 | $76 | $4 |
2019: 22 drugs
| Bupropion Xl | 52 | $3,570 | $69 |
| Duloxetine | 34 | $1,493 | $44 |
| Mirtazapine | 59 | $1,393 | $24 |
| Trazodone | 37 | $1,334 | $36 |
| Dextroamphetamine-Amphet Er | 11 | $1,244 | $113 |
| Aripiprazole | 17 | $1,139 | $67 |
| Venlafaxine Hcl Er | 30 | $990 | $33 |
| Escitalopram | 38 | $672 | $18 |
| Lithium Carbonate | 41 | $534 | $13 |
| Risperidone | 35 | $473 | $14 |
| Quetiapine | 25 | $464 | $19 |
| Sertraline | 31 | $449 | $14 |
| Dextroamphetamine-Amphetamine | 11 | $415 | $38 |
| Divalproex | 19 | $337 | $18 |
| Gabapentin | 16 | $309 | $19 |
| Clozapine | 14 | $287 | $21 |
| Lamotrigine | 32 | $241 | $8 |
| Nortriptyline | 18 | $222 | $12 |
| Clonazepam | 12 | $145 | $12 |
| Zolpidem | 16 | $141 | $9 |
| Lorazepam | 18 | $114 | $6 |
| Fluoxetine | 11 | $56 | $5 |
2018: 18 drugs
| Aripiprazole | 44 | $3,172 | $72 |
| Bupropion Xl | 70 | $3,132 | $45 |
| Clozapine | 34 | $1,745 | $51 |
| Duloxetine | 36 | $1,478 | $41 |
| Venlafaxine Hcl Er | 18 | $730 | $41 |
| Prazosin | 19 | $661 | $35 |
| Escitalopram | 32 | $450 | $14 |
| Mirtazapine | 17 | $404 | $24 |
| Sertraline | 30 | $322 | $11 |
| Quetiapine | 27 | $303 | $11 |
| Lithium Carbonate | 24 | $298 | $12 |
| Gabapentin | 14 | $276 | $20 |
| Lamotrigine | 22 | $253 | $12 |
| Bupropion Hcl Sr | 11 | $231 | $21 |
| Trazodone | 13 | $213 | $16 |
| Alprazolam | 13 | $212 | $16 |
| Fluoxetine | 18 | $185 | $10 |
| Olanzapine | 12 | $165 | $14 |
2017: 16 drugs
| Clomipramine | 12 | $6,626 | $552 |
| Duloxetine | 20 | $1,671 | $84 |
| Ziprasidone | 20 | $1,363 | $68 |
| Bupropion Xl | 29 | $1,001 | $35 |
| Trazodone | 26 | $548 | $21 |
| Prazosin | 15 | $454 | $30 |
| Escitalopram | 21 | $372 | $18 |
| Mirtazapine | 18 | $369 | $20 |
| Sertraline | 31 | $308 | $10 |
| Lithium Carbonate | 21 | $268 | $13 |
| Lamotrigine | 26 | $259 | $10 |
| Bupropion Hcl Sr | 14 | $258 | $18 |
| Venlafaxine Hcl Er | 16 | $240 | $15 |
| Quetiapine | 22 | $186 | $8 |
| Lorazepam | 16 | $154 | $10 |
| Olanzapine | 12 | $95 | $8 |
2016: 11 drugs
| Duloxetine | 13 | $1,285 | $99 |
| Mirtazapine | 15 | $599 | $40 |
| Bupropion Xl | 13 | $412 | $32 |
| Lamotrigine | 17 | $272 | $16 |
| Trazodone | 14 | $222 | $16 |
| Bupropion Hcl Sr | 11 | $209 | $19 |
| Fluoxetine | 15 | $198 | $13 |
| Lithium Carbonate | 17 | $173 | $10 |
| Venlafaxine Hcl Er | 11 | $163 | $15 |
| Sertraline | 27 | $158 | $6 |
| Lorazepam | 15 | $108 | $7 |
2015: 22 drugs
| Abilify | 51 | $50,522 | $991 |
| Aripiprazole | 18 | $9,372 | $521 |
| Clozapine | 39 | $3,949 | $101 |
| Ziprasidone | 27 | $2,849 | $106 |
| Olanzapine | 118 | $2,172 | $18 |
| Olanzapine Odt | 14 | $1,298 | $93 |
| Haloperidol | 27 | $1,187 | $44 |
| Divalproex Sodium Er | 17 | $1,129 | $66 |
| Divalproex | 55 | $1,059 | $19 |
| Benztropine Mesylate | 75 | $975 | $13 |
| Risperidone | 80 | $846 | $11 |
| Quetiapine | 42 | $784 | $19 |
| Sertraline | 63 | $435 | $7 |
| Trazodone | 38 | $253 | $7 |
| Clonazepam | 56 | $236 | $4 |
| Bupropion Hcl Sr | 20 | $227 | $11 |
| Lithium Carbonate | 25 | $166 | $7 |
| Escitalopram | 23 | $152 | $7 |
| Paroxetine | 17 | $137 | $8 |
| Mirtazapine | 14 | $121 | $9 |
| Citalopram Hbr | 23 | $99 | $4 |
| Lorazepam | 12 | $17 | $1 |
2014: 24 drugs
| Abilify | 54 | $49,436 | $915 |
| Divalproex Sodium Er | 84 | $18,089 | $215 |
| Olanzapine | 114 | $11,869 | $104 |
| Clozapine | 34 | $5,125 | $151 |
| Ziprasidone | 21 | $3,922 | $187 |
| Quetiapine | 23 | $2,875 | $125 |
| Haloperidol | 46 | $2,282 | $50 |
| Risperidone | 65 | $1,769 | $27 |
| Perphenazine | 14 | $1,619 | $116 |
| Haloperidol Decanoate | 15 | $1,001 | $67 |
| Benztropine Mesylate | 74 | $600 | $8 |
| Divalproex | 29 | $577 | $20 |
| Sertraline | 44 | $457 | $10 |
| Clonazepam | 83 | $394 | $5 |
| Bupropion Hcl Sr | 18 | $371 | $21 |
| Prazosin | 12 | $181 | $15 |
| Escitalopram | 16 | $151 | $9 |
| Trihexyphenidyl | 15 | $125 | $8 |
| Lorazepam | 23 | $111 | $5 |
| Trazodone | 15 | $91 | $6 |
| Nortriptyline | 11 | $90 | $8 |
| Propranolol | 16 | $75 | $5 |
| Metoprolol | 14 | $70 | $5 |
| Citalopram Hbr | 11 | $65 | $6 |
2013: 3 drugs
| Abilify | 14 | $11,224 | $802 |
| Divalproex Sodium Er | 18 | $2,294 | $127 |
| Risperidone | 11 | $240 | $22 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 74.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1740424654
- Licence
- CA 125619, NY 257572California A125619: Current · expires 2027-04-30
- Trained
- University of California, San Francisco School of Medicine, 2009 · 17 years ago
- Group
- University Healthcare Alliance · University of California San Francisco · UCSF Medical Group Business Services
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Psychiatry (2084P0800X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2009-04-22
- NPI last updated
- 2026-04-13
- NPI record certified
- 2026-04-13
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 20642 John Dr, Castro Valley, CA, 94546 · 1814 Franklin St, Oakland, CA, 94612